191 related articles for article (PubMed ID: 37266987)
1. Drugs for migraine.
Med Lett Drugs Ther; 2023 Jun; 65(1678):89-96. PubMed ID: 37266987
[No Abstract] [Full Text] [Related]
2. Drugs for Migraine.
Med Lett Drugs Ther; 2020 Oct; 62(1608):153-160. PubMed ID: 33434187
[No Abstract] [Full Text] [Related]
3. Lasmiditan (Reyvow) and ubrogepant (Ubrelvy) for acute treatment of migraine.
Med Lett Drugs Ther; 2020 Mar; 62(1593):35-39. PubMed ID: 32555120
[No Abstract] [Full Text] [Related]
4. Comparison table: Some drugs for migraine prevention in adults.
Med Lett Drugs Ther; 2023 Jun; 65(1678):e100-e102. PubMed ID: 37266989
[No Abstract] [Full Text] [Related]
5. Zavegepant (Zavzpret) for acute treatment of migraine.
Med Lett Drugs Ther; 2023 Jul; 65(1681):116-118. PubMed ID: 37460143
[No Abstract] [Full Text] [Related]
6. Atogepant (Qulipta) for migraine prevention.
Med Lett Drugs Ther; 2021 Nov; 63(1636):169-171. PubMed ID: 35085204
[No Abstract] [Full Text] [Related]
7. Eptinezumab (Vyepti) for migraine prevention.
Med Lett Drugs Ther; 2020 Jun; 62(1599):85-87. PubMed ID: 32555116
[No Abstract] [Full Text] [Related]
8. Fremanezumab (Ajovy) and galcanezumab (Emgality) for migraine prevention.
Med Lett Drugs Ther; 2018 Nov; 60(1559):177-180. PubMed ID: 30681655
[No Abstract] [Full Text] [Related]
9. Erenumab (Aimovig) for migraine prevention.
Med Lett Drugs Ther; 2018 Jun; 60(1549):101-103. PubMed ID: 29913472
[No Abstract] [Full Text] [Related]
10. Rimegepant (Nurtec ODT) for acute treatment of migraine.
Med Lett Drugs Ther; 2020 May; 62(1597):70-72. PubMed ID: 32555113
[No Abstract] [Full Text] [Related]
11. Comparison table: Triptans.
Med Lett Drugs Ther; 2023 Jun; 65(1678):e97-e99. PubMed ID: 37266988
[No Abstract] [Full Text] [Related]
12. A new dihydroergotamine nasal spray (Trudhesa) for migraine.
Med Lett Drugs Ther; 2021 Dec; 63(1640):204-207. PubMed ID: 35100240
[No Abstract] [Full Text] [Related]
13. The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.
Marmura MJ; Silberstein SD; Schwedt TJ
Headache; 2015 Jan; 55(1):3-20. PubMed ID: 25600718
[TBL] [Abstract][Full Text] [Related]
14. Acute Migraine Treatment in Adults.
Becker WJ
Headache; 2015 Jun; 55(6):778-93. PubMed ID: 25877672
[TBL] [Abstract][Full Text] [Related]
15. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
McCormack PL; Foster RH
Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
[TBL] [Abstract][Full Text] [Related]
16. Nonopioid drugs for pain.
Med Lett Drugs Ther; 2022 Mar; 64(1645):33-40. PubMed ID: 35231019
[No Abstract] [Full Text] [Related]
17. Pharmacological approaches to migraine.
Diener HCh
J Neural Transm Suppl; 2003; (64):35-63. PubMed ID: 12830928
[TBL] [Abstract][Full Text] [Related]
18. Acute Migraine Treatment.
Becker WJ
Continuum (Minneap Minn); 2015 Aug; 21(4 Headache):953-72. PubMed ID: 26252584
[TBL] [Abstract][Full Text] [Related]
19. Advances in pharmacological treatment of migraine.
Diener HC; Limmroth V
Expert Opin Investig Drugs; 2001 Oct; 10(10):1831-45. PubMed ID: 11772289
[TBL] [Abstract][Full Text] [Related]
20. Rational migraine management: optimising treatment with the triptans.
Millson DS
Funct Neurol; 2000; 15 Suppl 3():182-91. PubMed ID: 11200789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
